Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Geveko in connection with its new share issue
Mandate

Vinge advises Geveko in connection with its new share issue

February 25, 2010

AB Geveko (publ) has resolved to carry out a new share issue with preferential rights for the shareholders. Through the new issue, which is fully committed and underwritten, the company will raise approximately SEK 160 million excluding transaction costs. The new issue is subject to approval by the extraordinary shareholders’ meeting on 31 March 2010.

AB Geveko is listed on NASDAQ OMX Stockholm.

Vinge’s team consisted primarily of responsible partner Göran Nyström and the associates Anna Björk Larson and Emil Hedberg.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026

Vinge has advised IK Partners in connection with the acquisition of Selatek

 Vinge has advised IK Partners (“IK”) in connection with IK X Fund’s acquisition of SELATEK Holding AB (“Selatek”), a leading Swedish technical installation platform, from Amplio Private Equity AB and the minority shareholders.
April 20, 2026